| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6123764 | Journal of Infection and Chemotherapy | 2014 | 8 Pages |
Abstract
In conclusion, garenoxacin showed an efficacy rate of greater than 90% for suspected atypical pneumonia and confirmed atypical pneumonia. Garenoxacin is considered to be useful in daily practice.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Koichi Izumikawa, Akira Watanabe, Naoyuki Miyashita, Tadashi Ishida, Hiroaki Hosono, Satoru Kushimoto, Shigeru Kohno,